FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3160212422> ?p ?o ?g. }

• W3160212422 endingPage "1676" @default.
• W3160212422 startingPage "1665" @default.
• W3160212422 abstract "Dravet syndrome (DS) is a rare but catastrophic genetic epilepsy, with 80% of patients carrying a mutation in the SCN1A gene. Currently, no antiseizure drug (ASD) exists that adequately controls seizures. In the clinic, individuals with DS often present first with a febrile seizure and, subsequently, generalized tonic-clonic seizures that can continue throughout life. To facilitate the development of ASDs for DS, the contract site of the National Institute of Neurological Disorders and Stroke (NINDS) Epilepsy Therapy Screening Program (ETSP) has evaluated a mouse model of DS using the conditional knock-in Scn1aA1783V/WT mouse.Survival rates and temperature thresholds for Scn1aA1783V/WT were determined. Prototype ASDs were administered via intraperitoneal injections at the time-to-peak effect, which was previously determined, prior to the induction of hyperthermia-induced seizures. ASDs were considered effective if they significantly increased the temperature at which Scn1aA1783V/WT mice had seizures.Approximately 50% of Scn1aA1783V/WT survive to adulthood and all have hyperthermia-induced seizures. The results suggest that hyperthermia-induced seizures in this model of DS are highly refractory to a battery of ASDs. Exceptions were clobazam, tiagabine, levetiracetam, and the combination of clobazam and valproic acid with add-on stiripentol, which elevated seizure thresholds.Overall, the data demonstrate that the proposed model for DS is suitable for screening novel compounds for the ability to block hyperthermia-induced seizures and that heterozygous mice can be evaluated repeatedly over the course of several weeks, allowing for higher throughput screening." @default.
• W3160212422 created "2021-05-24" @default.
• W3160212422 creator A5011540948 @default.
• W3160212422 creator A5018948189 @default.
• W3160212422 creator A5052368478 @default.
• W3160212422 creator A5057940152 @default.
• W3160212422 creator A5058797510 @default.
• W3160212422 creator A5063039464 @default.
• W3160212422 creator A5071806289 @default.
• W3160212422 creator A5084554069 @default.
• W3160212422 creator A5085946560 @default.
• W3160212422 creator A5091663405 @default.
• W3160212422 date "2021-05-17" @default.
• W3160212422 modified "2023-10-17" @default.
• W3160212422 title "Development of an antiseizure drug screening platform for Dravet syndrome at the NINDS contract site for the Epilepsy Therapy Screening Program" @default.
• W3160212422 cites W1486327708 @default.
• W3160212422 cites W151118185 @default.
• W3160212422 cites W1806230115 @default.
• W3160212422 cites W1926532831 @default.
• W3160212422 cites W1992787503 @default.
• W3160212422 cites W2021906680 @default.
• W3160212422 cites W2027574016 @default.
• W3160212422 cites W2042400521 @default.
• W3160212422 cites W2043347984 @default.
• W3160212422 cites W2048186906 @default.
• W3160212422 cites W2052927837 @default.
• W3160212422 cites W2057408568 @default.
• W3160212422 cites W2064025488 @default.
• W3160212422 cites W2083064460 @default.
• W3160212422 cites W2105423985 @default.
• W3160212422 cites W2107939180 @default.
• W3160212422 cites W2120986114 @default.
• W3160212422 cites W2151323473 @default.
• W3160212422 cites W2170194739 @default.
• W3160212422 cites W2173417336 @default.
• W3160212422 cites W2399319535 @default.
• W3160212422 cites W2409651687 @default.
• W3160212422 cites W2513406030 @default.
• W3160212422 cites W2540532044 @default.
• W3160212422 cites W2568121822 @default.
• W3160212422 cites W2609649272 @default.
• W3160212422 cites W2610381892 @default.
• W3160212422 cites W2620218661 @default.
• W3160212422 cites W2761862301 @default.
• W3160212422 cites W2767723993 @default.
• W3160212422 cites W2778904613 @default.
• W3160212422 cites W2807232570 @default.
• W3160212422 cites W2887582341 @default.
• W3160212422 cites W2901578486 @default.
• W3160212422 cites W2905603477 @default.
• W3160212422 cites W2925073929 @default.
• W3160212422 cites W2942764308 @default.
• W3160212422 cites W2976958970 @default.
• W3160212422 cites W2978296444 @default.
• W3160212422 cites W2979896320 @default.
• W3160212422 cites W2980764484 @default.
• W3160212422 cites W2996672198 @default.
• W3160212422 cites W2998796218 @default.
• W3160212422 doi "https://doi.org/10.1111/epi.16925" @default.
• W3160212422 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8360068" @default.
• W3160212422 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34002394" @default.
• W3160212422 hasPublicationYear "2021" @default.
• W3160212422 type Work @default.
• W3160212422 sameAs 3160212422 @default.
• W3160212422 citedByCount "20" @default.
• W3160212422 countsByYear W31602124222021 @default.
• W3160212422 countsByYear W31602124222022 @default.
• W3160212422 countsByYear W31602124222023 @default.
• W3160212422 crossrefType "journal-article" @default.
• W3160212422 hasAuthorship W3160212422A5011540948 @default.
• W3160212422 hasAuthorship W3160212422A5018948189 @default.
• W3160212422 hasAuthorship W3160212422A5052368478 @default.
• W3160212422 hasAuthorship W3160212422A5057940152 @default.
• W3160212422 hasAuthorship W3160212422A5058797510 @default.
• W3160212422 hasAuthorship W3160212422A5063039464 @default.
• W3160212422 hasAuthorship W3160212422A5071806289 @default.
• W3160212422 hasAuthorship W3160212422A5084554069 @default.
• W3160212422 hasAuthorship W3160212422A5085946560 @default.
• W3160212422 hasAuthorship W3160212422A5091663405 @default.
• W3160212422 hasBestOaLocation W31602124222 @default.
• W3160212422 hasConcept C118552586 @default.
• W3160212422 hasConcept C126322002 @default.
• W3160212422 hasConcept C187212893 @default.
• W3160212422 hasConcept C2775858608 @default.
• W3160212422 hasConcept C2776749334 @default.
• W3160212422 hasConcept C2777172819 @default.
• W3160212422 hasConcept C2777332695 @default.
• W3160212422 hasConcept C2777341932 @default.
• W3160212422 hasConcept C2777907850 @default.
• W3160212422 hasConcept C2778186239 @default.
• W3160212422 hasConcept C2779426884 @default.
• W3160212422 hasConcept C2779949491 @default.
• W3160212422 hasConcept C2780623815 @default.
• W3160212422 hasConcept C42219234 @default.
• W3160212422 hasConcept C71924100 @default.
• W3160212422 hasConcept C98274493 @default.
• W3160212422 hasConceptScore W3160212422C118552586 @default.
• W3160212422 hasConceptScore W3160212422C126322002 @default.

• next